Glenmark USA Launches Calcium Gluconate Injection
· Business · Business Standard
Glenmark Pharmaceuticals' US subsidiary has launched Calcium Gluconate Injection USP, a medication used to treat calcium deficiencies. The product is now available for distribution to healthcare providers and hospitals across the United States. This injection is indicated for the treatment of hypocalcemia in various clinical settings. The company received approval from the US Food and Drug Administration to market this injectable drug. The launch expands the firm's portfolio of hospital-based products in the American market.
Why it matters
The availability of this generic injection provides healthcare facilities with an additional supply option for managing critical calcium-related medical conditions in patients.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.